Documents

Mis en évidence

Report to monitor the European clinical trials environment (January - March 2026)

Mis en évidence

ACT EU multi-annual workplan 2026-2027

Executive summary of ACT EU matrix meeting 1 October 2025

Report to monitor the European clinical trials environment (October - December 2025)

Report to monitor the European clinical trials environment (July - September 2025)

Mis en évidence

EU clinical trials during the 3 year CTR transition period

Report to monitor the European clinical trials environment (April - June 2025)

Report to monitor the European clinical trials environment (January - March 2025)

Mis en évidence

ACT EU multi-annual workplan 2025-2026

Report to monitor the European clinical trials environment (1-31 December 2024)

Report to monitor the European clinical trials environment (1-30 November 2024)

Report to monitor the European clinical trials environment (1-31 October 2024)

Report to monitor the European clinical trials environment (1-30 September 2024)

Report to monitor the European clinical trials environment (1-31 August 2024)

Report to monitor the European clinical trials environment (1-31 July 2024)

Report to monitor the European clinical trials environment (1-30 June 2024)

Report on the 2023 survey on the implementation of the Clinical Trials Regulation

Report to monitor the European clinical trials environment (1-31 May 2024)

Report to monitor the European clinical trials environment (1-30 April 2024)

Report to monitor the European clinical trials environment (1-31 March 2024)